ARCHIVES

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

This article is from The Cancer Letter archive.

Vol. 24 No. 01 | January 9, 1998

Download PDF Visit The Full Archive

Related Articles

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

NCI Alternative to Fixed Number Of Grants Not Popular At NIH; AACR Considers New Issues Groups

July 15, 1983

Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel

April 5, 1974

ODAC Chairman: Time Was Tight For Meeting

November 10, 1995

Cancer Research Isn’t A Priority In Bush Budget, AACR President Says.

February 9, 2007

Literature Review Supports Need for More Research In Cancer Control

July 19, 1985